Early-career postdoctoral researcher with a fellowship from the Alexander von Humboldt foundation.

 Education

Faculty of Pharmacy, Cairo University, Cairo, Egypt

PhD in Pharmacy (Pharmacology and Toxicology), July 2022

MSc in Pharmacy (Pharmacology and Toxicology), December 2018

BSc in Clinical Pharmacy, May 2013

• Employment

Faculty of Pharmacy, Cairo University, Cairo, Egypt, March 2014 – present

Lecturer at the Department of Pharmacology and Toxicology (October 2022 − present).

Assistant lecturer at the Department of Pharmacology and Toxicology (March 2019 − September 2022).

Teaching assistant at the Department of Pharmacology and Toxicology (March 2014 − March  2019).

• Current research project
  

  Working on the study proposal “Novel insights for management of ischaemic stroke outcomes through repurposing of approved antidiabetic SGLT2 inhibitors” with the involvement of a research team from the Department of Pharmacology and Toxicology at the Institute of Pharmacy, Freie Universität Berlin under the supervision of Prof. Dr. Burkhard Kleuser.

• Research interest

Cardiology, Oncology, and CNS researc

• Awards

- Alexander von Humboldt (Georg Forster) postdoctoral research fellowship at FUB (2025)

- Best PhD thesis in 2022 at the Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University

- Muhammad R.N., Albahairy M.A., Abd El Fattah M. A. Empagliflozin-activated AMPK elicits neuroprotective properties in reserpine-induced depression via regulating dynamics of hippocampal autophagy/inflammation and PKCζ-mediated neurogenesis. Psychopharmacology (2024). DOI: 10.1007/s00213-024-06663-0

- Muhammad, R.N., Ahmed, L.A., Abdul Salam, R.M. et al. Crosstalk Among NLRP3 Inflammasome, ETBR Signaling, and miRNAs in Stress-Induced Depression-Like Behavior: A Modulatory Role for SGLT2 Inhibitors. Neurotherapeutics (2021). https://doi.org/10.1007/s13311-021-01140-4

- Muhammad, R.N., Sallam, N. & El-Abhar, H.S. Activated ROCK/Akt/eNOS and ET-1/ERK pathways in 5-fluorouracil-induced cardiotoxicity: modulation by simvastatin. Sci Rep 10, 14693 (2020). https://doi.org/10.1038/s41598-020-71531-8